Bangkok Dusit Medical Services Public Company Limited (BDULF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 18.59 means the share price is 18.59 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $8.90B is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBangkok Dusit Medical Services Public Company Limited (BDULF) trades at $0.56. Bangkok Dusit Medical Services (BDMS) is Thailand's largest private hospital network, operating 47 hospitals across Thailand and Cambodia. Market cap: $8.90B, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for BDULF: BDULF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BDULF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
These figures come from statements filed 12 months ago — the most recent this company has published.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
BDULF: the 2 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Bangkok Dusit Medical Services Public Company Limited (BDULF) Healthcare & Pipeline Overview
Bangkok Dusit Medical Services (BDMS) is a leading healthcare provider in Thailand and Cambodia, operating a network of hospitals and offering diverse medical services, wellness programs, and pharmaceutical products, with a focus on both local and international patients and a strong dividend yield of 5.29%.
What Is the Investment Thesis for BDULF?
The company's extensive network of 47 hospitals and diverse service offerings cater to a broad patient base, driving consistent revenue. A profit margin of 14.2% and a gross margin of 36.1% demonstrate financial stability. The dividend yield of 5.29% offers an attractive return for investors. Growth catalysts include increasing medical tourism to Thailand, expansion of specialized medical services, and strategic investments in related healthcare businesses. However, potential risks include regulatory changes in the healthcare industry and economic fluctuations in Thailand and Cambodia.
Based on FMP financials and quantitative analysis
BDULF Key Highlights
Market capitalization of $8.90B, reflecting its strong position in the healthcare sector.
- P/E ratio of 18.59, indicating a reasonable valuation compared to earnings.
- Profit margin of 14.2%, showcasing efficient operations and profitability.
- Gross margin of 36.1%, demonstrating effective cost management in service delivery.
- Dividend yield of 5.29%, providing a substantial income stream for investors.
Who Are BDULF's Competitors?
BDULF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BIOVF Swedish Orphan Biovitrum AB (publ) | $48.13 | 0.00% | $16.7B | — |
| CSPCY CSPC Pharmaceutical Group Limited | $4.36 | -9.54% | $12.6B | — |
| GIFLF Grifols, S.A. | $11.33 | +2.26% | $7.71B | 529-signal |
| MTHRF M3, Inc. | $10.36 | 0.00% | $6.92B | 489-signal |
| ENSG The Ensign Group, Inc. | $172.79 | +0.60% | $10.1B | 745-pillar |
| UHS Universal Health Services, Inc. | $172.72 | -1.74% | $10.5B | 935-pillar |
| DVA DaVita Inc. | $181.33 | -0.92% | $11.6B | 745-pillar |
| CHE Chemed Corporation | $514.40 | -0.80% | $6.72B | 865-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are BDULF's Key Strengths?
Largest private hospital network in Thailand.
- Comprehensive range of medical services.
- Strong brand reputation.
- Established medical tourism business.
What Are BDULF's Weaknesses?
Reliance on the Thai economy.
- Exposure to regulatory changes in the healthcare industry.
- Competition from other hospital groups.
- Potential impact from global health crises.
What Could Drive BDULF Stock Higher?
Increasing medical tourism to Thailand, driven by affordable and high-quality healthcare services.
- Expansion of specialized medical services, such as cardiology and oncology, to attract more patients.
- Strategic investments in healthcare technology to improve efficiency and patient outcomes.
What Are the Key Risks for BDULF?
Economic downturns in Thailand and Cambodia, which could reduce demand for healthcare services.
- Increased competition from local and international hospital groups.
- Changes in government healthcare policies that could impact revenue and profitability.
- Fluctuations in currency exchange rates, which could affect the cost of imported medical equipment and supplies.
What Are the Growth Opportunities for BDULF?
- Expansion of Medical Tourism Services: Thailand is a well-known hub for medical tourism. BDMS can capitalize on this by enhancing its services for international patients, including specialized packages, multilingual support, and partnerships with international insurance providers. The global medical tourism market is projected to reach $272.7 billion by 2027, offering a substantial growth opportunity for BDMS.
- Development of Specialized Medical Centers: BDMS can further develop specialized medical centers focusing on high-demand areas such as cardiology, oncology, and orthopedics. These centers can attract both local and international patients seeking advanced treatments and specialized expertise. The market for specialized medical services is growing rapidly, driven by technological advancements and increasing prevalence of chronic diseases.
- Strategic Investments in Healthcare Technology: Investing in advanced healthcare technologies, such as telemedicine, AI-powered diagnostics, and robotic surgery, can improve efficiency, enhance patient outcomes, and attract tech-savvy patients. The global telemedicine market is projected to reach $41.4 billion by 2026, presenting a significant opportunity for BDMS to integrate technology into its service offerings.
- Expansion into Wellness and Preventive Care: BDMS can expand its focus on wellness and preventive care services, including health screenings, personalized wellness programs, and lifestyle coaching. This can attract a broader customer base and generate recurring revenue streams. The global wellness market is estimated at over $4.7 trillion, indicating a substantial opportunity for BDMS to capitalize on the growing demand for wellness services.
- Geographic Expansion within Southeast Asia: While BDMS already has a presence in Cambodia, further geographic expansion within Southeast Asia can tap into new markets and diversify revenue streams. Countries like Vietnam, Myanmar, and Laos offer significant growth potential due to their rapidly growing economies and increasing demand for quality healthcare services. Strategic partnerships and acquisitions can facilitate this expansion.
What Are BDULF's Competitive Advantages?
- Extensive network of hospitals providing broad geographic coverage.
- Strong brand reputation and recognition in Thailand and Southeast Asia.
- Comprehensive range of medical services catering to diverse patient needs.
- Established relationships with local and international insurance providers.
What Does BDULF Do?
Bangkok Dusit Medical Services Public Company Limited (BDMS), established in 1969 and headquartered in Bangkok, Thailand, is the largest private hospital network in Thailand. The company operates 47 hospitals in Thailand and Cambodia, managing them under six primary hospital groups: Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. These groups provide a comprehensive range of medical services, from general medical care to specialized treatments, catering to both local and international patients. BDMS has expanded its services beyond traditional hospital care to include holistic clinical wellness programs, hotels, and restaurants. The company also sells health and cosmetic products and provides various support services such as accounting, health insurance, laboratory services, investment, information technology, training, skin and aesthetics telemedicine, genome sequencing, insurance brokerage, air medical transportation, facility management, property management services, and asset management services. Furthermore, BDMS is involved in manufacturing and distributing medicine and pharmaceutical products, along with e-commerce and real estate ventures, diversifying its revenue streams and solidifying its position as a comprehensive healthcare provider in the region.
What Products and Services Does BDULF Offer?
- Operates a network of 47 hospitals in Thailand and Cambodia.
- Provides a wide range of medical services, including general and specialized treatments.
- Offers holistic clinical wellness programs.
- Sells health and cosmetic products.
- Provides accounting, health insurance, and laboratory services.
- Offers telemedicine and genome sequencing services.
- Manufactures and distributes medicine and pharmaceutical products.
How Does BDULF Make Money?
- Generates revenue from hospital services, including inpatient and outpatient care.
- Earns income from wellness programs and related health services.
- Sells pharmaceutical products and medical supplies.
- Provides support services such as health insurance and laboratory testing.
What Industry Does BDULF Operate In?
Bangkok Dusit Medical Services operates within the growing healthcare industry in Southeast Asia, driven by increasing affluence, aging populations, and rising demand for quality medical services. Thailand is a popular destination for medical tourism, attracting patients from around the world seeking affordable and high-quality treatments. The competitive landscape includes both local and international hospital groups. BDMS differentiates itself through its extensive network, comprehensive service offerings, and strong brand reputation. The industry is expected to continue growing, driven by both domestic and international demand.
Who Are BDULF's Key Customers?
- Local Thai patients seeking general and specialized medical care.
- International patients seeking medical tourism services.
- Corporations and organizations providing health benefits to their employees.
- Individuals seeking wellness and preventive care services.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 52 |
| 2026-08-26 | 52 |
| 2026-08-29 | 52 |
| 2026-09-01 | 52 |
| 2026-09-04 | 52 |
| 2026-09-07 | 52 |
| 2026-09-10 | 52 |
What changed?
The score has stayed at 52.
Over the same 18 days the stock moved +0.0%.
Forward Outlook
Wall Street analysts project Bangkok Dusit Medical Services Public Company Limited revenue of about $114.77B for fiscal 2026, with EPS near $0.00. The estimate reflects 12 contributing analysts.
Quarterly Financial Performance: Bangkok Dusit Medical Services Public Company Limited
Revenue for Bangkok Dusit Medical Services Public Company Limited came in at $26.87B during Jun 2026, a 4.7% contraction versus the preceding quarter. The company recorded net income of $3.24B, with diluted EPS of $0.20. Revenue has contracted over three consecutive quarters, which investors in this mid-cap Healthcare stock should monitor closely. Across the four most recent quarters, BDULF averaged $0.24 in diluted EPS.
BDULF Valuation & Market Position
With a $8.90B market cap, Bangkok Dusit Medical Services Public Company Limited sits in the mid-cap segment of the market.
Key Financial Metrics
Return on equity for Bangkok Dusit Medical Services Public Company Limited stands at 14.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 9.7%, showing how much profit it generates from its asset base. BDULF trades at a trailing price-to-earnings ratio of 18.59, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 4.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.16 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.4%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Bangkok Dusit Medical Services Public Company Limited's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 5.04 places it in the safe zone, indicating low near-term bankruptcy risk.
Company Profile
Bangkok Dusit Medical Services Public Company Limited operates in the Medical Care Facilities industry within the Healthcare sector. It is headquartered in Bangkok, Thailand.
BDULF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Largest private hospital network in Thailand.
- Comprehensive range of medical services.
- Strong brand reputation.
- Established medical tourism business.
Bear Case
- Reliance on the Thai economy.
- Exposure to regulatory changes in the healthcare industry.
- Competition from other hospital groups.
- Potential impact from global health crises.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Jun 2026 | THB 26.87B | THB 3.24B | THB 0.20 |
| Mar 2026 | THB 28.21B | THB 4.06B | THB 0.26 |
| Dec 2025 | THB 28.43B | THB 3.69B | THB 0.23 |
| Sep 2025 | THB 28.24B | THB 4.32B | THB 0.27 |
Based on FMP financials and quantitative analysis · Reported in THB
BDULF Latest News
No recent news available for BDULF.
BDULF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BDULF.
Price Targets
Wall Street price target analysis for BDULF.
BDULF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for BDULF; grades run from A+ (80-100) to F (below 30).
Leadership: Poramaporn Prasarttong-Osoth
CEO
Poramaporn Prasarttong-Osoth is the Chief Executive Officer of Bangkok Dusit Medical Services Public Company Limited. However, as CEO, she is responsible for leading the strategic direction and overall management of the largest private hospital network in Thailand.
Track Record: Under Poramaporn Prasarttong-Osoth's leadership, Bangkok Dusit Medical Services has maintained its position as the leading healthcare provider in Thailand and has continued to expand its network and services. Specific achievements and milestones during her tenure are not detailed in the provided source data, but the company's consistent financial performance and market leadership suggest a successful track record.
BDULF OTC Market Information
The OTC Other tier, where BDULF trades, represents the lowest tier of the OTC market. Companies in this tier often have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies do not have to meet minimum listing standards, such as requirements for market capitalization, share price, and financial reporting. This lack of regulation and oversight increases the risk associated with investing in these companies.
- OTC Tier: OTC Other
- Limited or no financial disclosure, making it difficult to assess the company's financial health.
- Low trading volume and liquidity, leading to price volatility and difficulty in executing trades.
- Lack of regulatory oversight and minimum listing standards, increasing the risk of fraud or mismanagement.
- Potential for delisting or suspension of trading due to non-compliance with OTC market regulations.
- Higher risk of price manipulation due to the lack of transparency and oversight.
- Verify the company's registration and legal status.
- Attempt to obtain and review any available financial statements, even if unaudited.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price activity for any unusual patterns.
- Consult with a financial advisor before making any investment decisions.
- The company has been in operation since 1969, indicating a long history.
- It operates a large network of hospitals in Thailand and Cambodia.
- It is a publicly traded company, even though it's on the OTC market.
- The company has a recognized CEO, Poramaporn Prasarttong-Osoth.
Bangkok Dusit Medical Services Public Company Limited Healthcare Stock: Key Questions Answered
Is BDULF a good stock?
Stock Expert AI does not rate BDULF buy, sell or hold. Bangkok Dusit Medical Services Public Company Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about BDULF stock?
Generally, healthcare stocks are evaluated based on factors such as revenue growth, profit margins, and market share. Investors also consider the company's ability to innovate and adapt to changing healthcare trends. BDULF's dividend yield of 5.29% may be an important factor for investors seeking income. Further analysis is needed to provide a comprehensive assessment of the stock's potential.
What are the key factors to evaluate for BDULF?
Evaluate BDULF on fundamentals, analyst consensus, and risk factors. P/E: 18.59x vs the S&P 500's ~20-25x. A profit margin of 14.2% and a gross margin of 36.1% demonstrate financial stability. Not financial advice.
How frequently does BDULF data refresh on this page?
BDULF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven BDULF's recent stock price performance?
Bangkok Dusit Medical Services Public Company Limited (BDULF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Largest private hospital network in Thailand. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BDULF overvalued or undervalued right now?
Bangkok Dusit Medical Services Public Company Limited (BDULF) trades at 18.59x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of BDULF?
Yes, most major brokerages offer fractional shares of Bangkok Dusit Medical Services Public Company Limited (BDULF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track BDULF's earnings and financial reports?
Bangkok Dusit Medical Services Public Company Limited (BDULF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for BDULF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC analysis is based on general characteristics of the OTC market and may not be specific to BDULF.